Skip to main content
Policy & Funding· Daily Pulse

The Senate Just Bought Hemp THC Products One More Month. Nobody Thinks a Month Fixes This.

An 89-4 vote pushed the federal hemp ban from November to December. The lopsided margin says more about how unresolved this fight is than any actual resolution does.

ByThe Rize NewsroomAugust 11, 20262 min readCannabinoids

The Senate Just Bought Hemp THC Products One More Month. Nobody Thinks a Month Fixes This.

Eighty-nine senators voted for it. Four voted against it. And what they voted for was, functionally, permission to keep arguing.

A vote that lopsided isn’t consensus — it’s an entire chamber agreeing they haven’t figured out what to do yet.

The Senate’s 89-4 vote, reported August 11 by Marijuana Moment, pushes a federal deadline that would have recriminalized most hemp-derived THC products — the drinks, gummies, and vapes sold at gas stations and dispensaries under the 2018 Farm Bill’s hemp carve-out — from November 12 to December 11, 2026. It rode inside a stopgap funding bill, which is usually where Congress parks fights it isn’t ready to have in the open. The bill still needs House approval and a presidential signature before the delay is real, so even this modest breathing room isn’t locked in yet.

What made the vote notable wasn’t the outcome. It was who was in the room agreeing on it. Majority Leader John Thune and Minority Leader Chuck Schumer both voted yes — a pairing that doesn’t happen on cannabis policy by accident. Sen. Rand Paul offered the most useful line of the day, pointing out that the industries lobbying hardest against hemp THC products aren’t just cannabis-adjacent competitors — some of it is coming from the alcohol industry, which has spent the past several years watching hemp beverages eat into the exact market segment (low-proof, social, drink-adjacent) that alcohol used to own uncontested.

That’s the part worth sitting with if you work in treatment or policy: this isn’t a fight about whether intoxicating hemp products are safe. Almost nobody arguing about the December deadline is making that argument in good faith. It’s a fight about which industry gets to sell a mildly intoxicating product to the same customer, under which regulatory umbrella, paying which taxes. A 5mg-THC seltzer and a can of hard seltzer are competing for the same Tuesday-night decision, and Washington is currently the referee for that fight, not for public health.

For providers: if your clients or patients are using hemp THC beverages as a lower-stakes alternative to alcohol — a real harm-reduction pattern some people land on without any formal program’s help — don’t assume the product’s legal status will hold still. A one-month delay is not a stable regulatory floor to build a treatment plan’s assumptions on. Ask about it directly this week if it hasn’t come up.

The version of this story that would actually matter is a permanent framework — the kind Reps. Beth Van Duyne and Greg Landsman introduced this month, capping hemp beverages at 5mg of THC per serving and taxing them like alcohol instead of leaving them in a legal gray zone. Congress isn’t there yet. It just proved, again, that it knows it isn’t.

Filed Under

policytrends

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section